CVE CENOVUS ENERGY INC

Ownership history in Mraz, Amerine & Associates, Inc.  ·  21 quarters on record

AI Ownership Summary

Mraz, Amerine & Associates, Inc. reported CENOVUS ENERGY INC (CVE) in 21 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.97% in 2025 Q3. The latest visible filing shows CVE at 0.91% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CVE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Mraz, Amerine & Associates, Inc.'s position in CENOVUS ENERGY INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

CVE was reported at 0.91% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.97% in 2025 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Mraz, Amerine & Associates, Inc. held CVE — position size vs. price
% of Fund (quarterly)    CVE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 363,218 -3,381 -0.9% 0.91% $6.1M 2026-02-14 (Est.) $21.82
2025 Q3 ADDED 366,599 +35,201 +10.6% 0.97% $6.2M 2025-11-06 $16.71
2025 Q2 ADDED 331,398 +65,305 +24.5% 0.72% $4.5M 2025-07-23 $14.54
2025 Q1 ADDED 266,093 +80,785 +43.6% 0.63% $3.7M 2025-04-30 $11.58
2024 Q4 ADDED 185,308 +50,190 +37.1% 0.50% $2.8M 2025-01-31 $14.10
2024 Q3 ADDED 135,118 +80,607 +147.9% 0.41% $2.3M 2024-10-23 $16.13
2024 Q2 ADDED 54,511 +10,996 +25.3% 0.22% $1.1M 2024-08-01 $18.06
2024 Q1 ADDED 43,515 +8,322 +23.6% 0.16% $870K 2024-05-15 $19.09
2023 Q4 ADDED 35,193 +18,985 +117.1% 0.12% $586K 2024-01-31 $15.23
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Mraz, Amerine & Associates, Inc. and CVE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Mraz, Amerine & Associates, Inc. reported owning CVE?

Mraz, Amerine & Associates, Inc. reported CVE across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported CVE position in Mraz, Amerine & Associates, Inc.'s portfolio?

The largest reported portfolio weight for CVE was 0.97% in 2025 Q3.

What is the latest reported CVE position on this page?

The most recent filing on this page is 2025 Q4, when Mraz, Amerine & Associates, Inc. reported 363,218 shares, equal to 0.91% of portfolio, with an estimated market value of $6.1M.

What does the chart on this CVE ownership page compare?

The chart compares Mraz, Amerine & Associates, Inc.'s quarterly CVE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Mraz, Amerine & Associates, Inc. Holdings